MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 182 filers reported holding MEDICINES CO in Q4 2013. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $648,273,000 | +73.5% | 7,632,116 | +2.1% | 0.02% | +57.1% |
| Q3 2019 | $373,735,000 | +37.8% | 7,474,698 | +0.5% | 0.01% | +40.0% |
| Q2 2019 | $271,297,000 | +39.1% | 7,438,930 | +6.6% | 0.01% | +25.0% |
| Q1 2019 | $195,059,000 | +48.6% | 6,978,866 | +1.7% | 0.01% | +33.3% |
| Q4 2018 | $131,297,000 | -34.3% | 6,859,838 | +2.7% | 0.01% | -25.0% |
| Q3 2018 | $199,846,000 | -16.5% | 6,681,573 | +2.5% | 0.01% | -20.0% |
| Q2 2018 | $239,242,000 | +15.7% | 6,518,871 | +3.8% | 0.01% | +11.1% |
| Q1 2018 | $206,827,000 | +21.1% | 6,278,917 | +0.6% | 0.01% | +28.6% |
| Q4 2017 | $170,726,000 | -24.3% | 6,244,562 | +2.5% | 0.01% | -36.4% |
| Q3 2017 | $225,629,000 | -2.5% | 6,091,522 | +0.1% | 0.01% | 0.0% |
| Q2 2017 | $231,419,000 | -22.3% | 6,088,386 | -0.0% | 0.01% | -26.7% |
| Q1 2017 | $297,837,000 | +51.9% | 6,090,730 | +5.4% | 0.02% | +36.4% |
| Q4 2016 | $196,066,000 | -6.8% | 5,776,854 | +3.6% | 0.01% | -8.3% |
| Q3 2016 | $210,363,000 | +15.3% | 5,574,023 | +2.8% | 0.01% | +9.1% |
| Q2 2016 | $182,388,000 | +10.0% | 5,423,391 | +3.9% | 0.01% | 0.0% |
| Q1 2016 | $165,872,000 | -11.7% | 5,220,999 | +3.8% | 0.01% | -15.4% |
| Q4 2015 | $187,855,000 | +0.6% | 5,030,912 | +2.3% | 0.01% | +85.7% |
| Q3 2015 | $186,695,000 | +36.6% | 4,918,209 | +2.9% | 0.01% | -22.2% |
| Q2 2015 | $136,683,000 | +5.5% | 4,777,480 | +3.3% | 0.01% | 0.0% |
| Q1 2015 | $129,547,000 | +7.6% | 4,623,415 | +6.3% | 0.01% | 0.0% |
| Q4 2014 | $120,364,000 | +25.6% | 4,349,986 | +1.3% | 0.01% | +28.6% |
| Q3 2014 | $95,823,000 | -22.4% | 4,293,172 | +1.0% | 0.01% | -30.0% |
| Q2 2014 | $123,471,000 | +0.9% | 4,248,852 | -1.4% | 0.01% | 0.0% |
| Q1 2014 | $122,409,000 | -24.1% | 4,307,145 | +3.1% | 0.01% | -28.6% |
| Q4 2013 | $161,347,000 | +19.2% | 4,177,805 | +3.5% | 0.01% | +7.7% |
| Q3 2013 | $135,338,000 | +20.4% | 4,037,527 | +10.5% | 0.01% | +8.3% |
| Q2 2013 | $112,444,000 | – | 3,655,514 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |